Filing Details
- Accession Number:
- 0001127602-19-020530
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-03 17:35:56
- Reporting Period:
- 2019-05-30
- Accepted Time:
- 2019-06-03 17:35:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199735 | Sally Crawford | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-30 | 1,726 | $0.00 | 28,469 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 5,235 | $28.87 | 33,704 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 3,587 | $40.60 | 37,291 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 5,525 | $27.37 | 42,816 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 2,000 | $20.90 | 44,816 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 4,000 | $17.75 | 48,816 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 4,000 | $30.04 | 52,816 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 4,000 | $35.11 | 56,816 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-31 | 28,347 | $108.60 | 28,469 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 5,235 | $0.00 | 5,235 | $28.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 3,587 | $0.00 | 3,587 | $40.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 5,525 | $0.00 | 5,525 | $27.37 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 2,000 | $0.00 | 2,000 | $20.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 4,000 | $0.00 | 4,000 | $17.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 4,000 | $0.00 | 4,000 | $30.04 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-31 | 4,000 | $0.00 | 4,000 | $35.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-04-30 | 2026-05-11 | No | 4 | M | Direct |
| 0 | 2018-04-30 | 2027-05-17 | No | 4 | M | Direct |
| 0 | 2025-05-13 | No | 4 | M | Direct | |
| 0 | 2021-05-12 | No | 4 | M | Direct | |
| 0 | 2022-06-01 | No | 4 | M | Direct | |
| 0 | 2023-06-03 | No | 4 | M | Direct | |
| 0 | 2024-06-02 | No | 4 | M | Direct |
Footnotes
- Annual equity award in the form of restricted stock units ("RSUs"). RSUs vest in full on April 30, 2020 and are settled in shares of common stock on a one-for-one basis.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $106.965 to $110.395. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2012, 25% of the total award vesting on April 30, 2013 and 25% of the total award vesting on April 30, 2014, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2013, 25% of the total award vesting on April 30, 2014 and 25% of the total award vesting on April 30, 2015, subject to continued service as a director or consultant.
- This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2015, 25% of the total award vesting on April 30, 2016 and 25% of the total award vesting on April 30, 2017, subject to continued service as a director or consultant.
Billionaire Hedge Funds
